How concerned should we be here in Idaho about … well ... fill in the blank: monkeypox, measles, shingles, malaria. Is it safe to travel internationally? Should I be worried about malaria in Idaho? How does monkeypox spread? Will the Adderall shortage affect my child's ADHD treatment? What’s the latest COVID-19 variant and is there a booster shot for that?
Every Wednesday, the Idaho Matters Doctors Roundtable with Dr. David Pate answers your question to keep all of us better prepared for public health crises in our community.
Have a question for our doctors roundtable? Email us: idahomatters@boisestate.edu.
-
The CDC’s Advisory Committee on Immunization Practices, known as ACIP, met last week to review and update our nation’s vaccine recommendations. -
A major medical breakthrough is offering some hope for families battling Huntington’s disease. -
During a televised news conference, the president stated that there was a link between Tylenol use in pregnancy and autism. In the time since that claim many experts have come out saying the evidence simply doesn’t support his theory. -
A new joint investigation from NBC News and Stanford University found that childhood vaccination rates across the U.S. are slipping. -
As some politicians in our country push the message of personal choice on vaccinations, doctors and infectious disease experts are sounding the alarm. -
Calls for the resignation of Robert F. Kennedy Jr. from his position within the Department of Health and Human Services are intensifying as more than 1,000 employees voice concerns over his controversial public health views. -
Across the United States there’s growing concern over the nation’s infant mortality rate. -
Hundreds of people may have been exposed to rabies in Wyoming, Eli Lilly has a new GLP-1 pill to help people lose weight and doctors may become dependent on AI. -
Have researchers found the key to Alzheimer's disease? We'll look at a new study. -
The Department of Health and Human Services is pulling five hundred million dollars in funding from 22 mRNA vaccine projects that target COVID-19, the flu and other respiratory viruses.
